Selank
Tuftsin analog. Selank is not FDA approved for any use.
Key facts
- Class
- Tuftsin analog
- Also called
- No common aliases
- Vial sizes sold
- 5 mg, 10 mg
- Community-reported sizes
- Half-life
- Not found
- No published half-life found (PubMed search, 11 Oct 2026)
- FDA status
- Not approved
- research chemical
- WADA
- Unclear
- Not named on the 2026 list
Selank guides
Explained
Evidence at a glance
Human and animal counts are PubMed records from our evidence ledger (search counts, not studies we reviewed). The grade is the strongest design among the studies we summarised for that goal: a human randomized trial outweighs any number of animal studies.
| Condition | Human studies | Animal studies | Studies we summarised | Evidence grade |
|---|---|---|---|---|
| Depression | 2 | 5 | 1 | Animal evidence, 2 of 4Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 2008, PMID 18661785 |
| Stress | Not in our ledger | Not in our ledger | 0 | No graded study for this goal |
| Sleep | 3 | 0 | 0 | No graded study for this goal |
| Anxiety | 7 | 27 | 10 | Human RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2015, PMID 26356395 |
| Cognition | 2 | 11 | 6 | Human RCT evidence, 4 of 4Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 2014, PMID 25176261 |
Grades follow our evidence scale. Summarised studies come from our evidence file, each quote checked against the abstract or label.
A synthetic tuftsin analogue
Selank is a synthetic analogue of tuftsin, a naturally occurring peptide.[11]
The proposed mechanism is inhibition of enkephalin-degrading enzymes: selank inhibited the breakdown of enkephalin in plasma in the lab.[12]
The human evidence covers anxiety only, against an active comparator
In patients with generalized anxiety disorder and neurasthenia, the anxiolytic effects of selank and the comparator drug were similar; selank was also reported to have antiasthenic and psychostimulant effects.[13]
In a comparison with phenazepam, the anxiolytic effect lasted for a week after the last dose of selank.[9]
In mice, selank increased the half-life of plasma leu-enkephalin and produced an anxiolytic effect in BALB/c mice but not in C57Bl/6 mice. This is animal data.[14]
Regulatory path
Drugs@FDA has no selank product.[2]
FDA's safety-risk table lists an immunogenicity risk for compounded selank acetate by certain routes of administration.[3]
Compared with
Common stacks
Selank is often sold pre-mixed or combined with other peptides. A few of these pairs appear together in published studies; each stack page lists what was tested, and the pages below cover the math and what each part has been studied for.
Common questions
Is Selank FDA approved?
No. Selank is not FDA approved for any use.
How much water goes in a 10 mg vial?
That choice only changes the concentration. With 2 mL, the vial is 5 mg/mL. The calculator converts any amount to syringe units. It does the math only and does not suggest a dose.
What is selank?
A synthetic analogue of tuftsin, studied for anxiety.[11]
What does selank do?
In a trial in patients with generalized anxiety disorder and neurasthenia, its anxiolytic effects were similar to those of a comparator drug.[13]
Is there a selank nasal spray?
A mouse study compared intranasal and intraperitoneal selank; no human nasal-spray data were found.[15]
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "selank" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3US compounding: Selank acetate appears in FDA's table of bulk drug substances previously in category 2 and withdrawn by the nominators.U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 4[Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice].Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova · 2008PMID 18661785Accessed 2 Oct 2026
- 5[Optimization of the treatment of anxiety disorders with selank].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2015PMID 26356395Accessed 2 Oct 2026
- 6PubMed search: selank[tiab] (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: selank[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) (4 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 8PubMed search: (selank[tiab] OR semax[tiab]) AND (randomized[tiab] OR patients[tiab] OR clinical[tiab]) (48 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 9[A comparison of the anxiolytic effect and tolerability of selank and phenazepam in the treatment of anxiety disorders].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2014PMID 25176261Accessed 2 Oct 2026
- 10PubMed search: selank[tiab] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (7 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 11Selank, Peptide Analogue of Tuftsin, Protects Against Ethanol-Induced Memory Impairment by Regulating of BDNF Content in the Hippocampus and Prefrontal Cortex in Rats.Bulletin of experimental biology and medicine · 2019PMID 31625062Accessed 2 Oct 2026
- 12The inhibitory effect of Selank on enkephalin-degrading enzymes as a possible mechanism of its anxiolytic activity.Bulletin of experimental biology and medicine · 2001PMID 11550013Accessed 2 Oct 2026
- 13[Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia].Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova · 2008PMID 18454096Accessed 2 Oct 2026
- 14Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions.Bulletin of experimental biology and medicine · 2002PMID 12432865Accessed 2 Oct 2026
- 15[COMPARISON OF PHARMACOLOGICAL EFFECTS OF HEPTAPEPTIDE SELANK AFTER INTRANASAL AND INTRAPERITONEAL ADMINISTRATION TO BALB/c AND C57BL/6 MICE.].Eksperimental'naia i klinicheskaia farmakologiia · 2016PMID 29787664Accessed 2 Oct 2026
Found an error? Report a correction.